UPOTREBA PSIHOAKTIVNIH SUPSTANCI U REGIONALNOM METADONSKOM CENTRU U SRBIJI

Tamara Popović; Aleksandra Dickov; Vladimir Knežević; Svetlana Ivanović Kovačević; Božana Nikolić

Tamara Popović Psychiatry Clinic, University Clinical Center of Vojvodina; Novi Sad, Serbia
Aleksandra Dickov Psychiatry Clinic, University Clinical Center of Vojvodina; Novi Sad, Serbia; University of Novi Sad, Faculty of Medicine, Department of Psychiatry and Psychological Medicine; Novi Sad, Serbia
Vladimir Knežević Psychiatry Clinic, University Clinical Center of Vojvodina, Novi Sad, Serbia; University of Novi Sad, Faculty of Medicine, Department of Psychiatry and Psychological Medicine, Novi Sad, Serbia
Svetlana Ivanović Kovačević Psychiatry Clinic, University Clinical Center of Vojvodina, Novi Sad, Serbia; University of Novi Sad, Faculty of Medicine, Department of Psychiatry and Psychological Medicine, Novi Sad, Serbia
Božana Nikolić Department of Pharmacy, Faculty of Medicine of Novi Sad, University of Novi Sad, Novi Sad, Serbia; Helth Center Novi Sad, Novi Sad, Serbia

Keywords: methadone maintenance therapy, psychoactive substance, prevalence, ASSIST score, risk of dependence

Abstract

Introduction: Patients on methadone maintenance therapy often use psychoactive substances (nicotine, alcohol, cannabis, cocaine, amphetamine-type stimulants, sedatives, hypnotics, hallucinogens and others), which can negatively affect therapeutic outcomes. The aim of this study was to determine the prevalence and pattern of psychoactive substance use among patients on methadone maintenance therapy.

Methods: The study was conducted in the Methadone Center of the University Clinical Center of Vojvodina in the period August-October 2022. Data were collected through general and ASSIST (The Alcohol, Smoking and Substance Involvement Screening Test) questionnaires. Descriptive statistics was used to analyze the collected data.

Results: In total, 60 patients on methadone maintenance therapy were included in the study. Among them, the prevalence of the use of nicotine, alcohol and illicit psychoactive substances was 98.3%, 10% and 5.1%, respectively, in the last 3 months preceding the investigation. The use of illicit psychoactive substances was mostly occasional. Three patients had ASSIST score >27 which was associated with a high risk of developing dependence to alcohol (two patients) or cannabis (1 patient).

Conclusion: The study indicated a significant difference in the prevalence of the use of licit and illicit psychoactive substances. Therefore, their use should be monitored through regular and occasional urinalysis.

References

European Monitoring Centre for Drugs and Drug Addiction. European Drug Report 2023: Trends and Developments. Lisbon: European Monitoring Centre for Drugs and Drug Addiction, 2023. (Available at https://www.emcdda.europa.eu/publications/european-drug-report/2023_en)

Lim J, Farhat I, Douros A, Panagiotoglou D. Relative effectiveness of medications for opioid-related disorders: A systematic review and network meta-analysis of randomized controlled trials. PLoS One. 2022; 31;17(3): e0266142. doi: 10.1371/journal.pone.0266142.

McBrien H, Luo C, Sanger N, Zielinski L, Bhatt M, Zhu XM, et al. Cannabis use during methadone maintenance treatment for opioid use disorder: a systematic review and meta-analysis. CMAJ Open. 2019;7(4): E665-E673. doi: 10.9778/cmajo.20190026

Charoensakulchai S, Onwan M, Kanchanasurakit S, Flaherty G, Matsee W. Recreational substance use among international travelers. J Travel Med. 2024: taae012. doi: 10.1093/jtm/taae012.

Scott TM, Arnsten J, Olsen JP, Arias F, Cunningham CO, Mindt MR. Neurocognitive, psychiatric, and substance use characteristics in a diverse sample of persons with OUD who are starting methadone or buprenorphine/naloxone in opioid treatment programs. Addict Sci Clin Pract 2021;16(1):64. doi: 10.1186/s13722-021-00272-4.

Custodio L, Malone S, Bardo MT, Turner JR. Nicotine and opioid co-dependence: Findings from bench research to clinical trials. Neurosci Biobehav Rev. 2022; 134:104507. doi: 10.1016/j.neubiorev.2021.12.030.

Le TA, Pham DTT, Quek TTC, Vu GT, Hoang CL, Tran TT, et al. Polysubstance Use among Patients Enrolling in Methadone Maintenance Treatment Program in a Vietnam Province with Drug-Driven HIV Epidemic. Int J Environ Res Public Health. 2019;16(18):3277. doi: 10.3390/ijerph16183277

Soyka M. Alcohol Use Disorders in Opioid Maintenance Therapy: Prevalence, Clinical Correlates and Treatment. Eur Addict Res. 2015;21(2):78-87. doi: 10.1159/000363232

Kleykamp BA, Vandrey RG, Bigelow GE, Strain EC, Mintzer MZ. Effects of methadone plus alcohol on cognitive performance in methadone-maintained volunteers. Am J Drug Alcohol Abuse. 2015;41(3):251-6. doi: 10.3109/00952990.2014.987348.

Heikman PK, Muhonen LH, Ojanpera A. polydrug abuse among opioid maintenance treatment patients is related to inadequate dose of maintenance treatment medicine. BMC Psychiatry. 2017:17(1):245. doi: 10.1186/s12888-017-1415-y.

Le NT, Khuong QL, Vu TTV, Thai TT, Le HTCH, Dao PT, et al. Prevalence of Amphetamine-Type Stimulant Use and Related Factors among Methadone Maintenance Patients in Ho Chi Minh City Vietnam: A Cross-Sectional Study. J Psychoactive Drugs. 2021;53(4):355-363. doi: 10.1080/02791072.2020.1871126.

Tran BX, Ohinmaa A, Mills S, Duong AT, Nguyen LT, Jacobs P, et al. Multilevel predictors of concurrent opioid use during methadone maintenance treatment among drug users with HIV/AIDS. PLoS One. 2012;7(12): e51589. doi: 10.1371/journal.pone.0051569.

Lin C, Cao X, Li L. Psychoactive Substance Use among Methadone Maintenance Therapy Clients in China. Ment Health Addict. 2017;15(4):801-11. doi: 10.1007/s11469-017-9758-7

Ngarachu EW, Kiburi SK, Owiti FR, Kangethe R. The prevalence and pattern of cannabis use among patients attending a methadone treatment clinic in Nairobi, Kenya. Subst Abuse Treat Prev Policy. 2022; 17:12. doi: 10.1186/s13011-022-00437-7

Alías-Ferri M, Pellegrini M, Marchei E, Pacifici R, Rotolo MC, Pichini S, et al. New Psychoactive Substances Consumption in Opioid-Use Disorder Patients. Biology (Basel). 2022;11(5):645. doi: 10.3390/biology11050645.

Vučković N, Dickov A, Коvačević M, Simonović P, Nikolić M, Jovanović M, et al. Supstituciona terapija zavisnika od opijata. Izmena i dopuna nacionalnioh smernica. Beograd: Ministarstvo zdravlja Republike Srbije, Republička stručna komisijaza prevenciju i kontrolu bolesti zavisnosti; 2012.

Verster A, Bunning E. Metahdone Guidelines. Project European Commission; 2000. Dostupno na: https://www.q4q.nl/euromethwork/home/publications/methadone-guidelines

World Health Organization. The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST). Geneva: World Health Organization; 2010. (https://www.afro.who.int/ publications/alcohol-smoking-and-substance-involvement-screening-test-assist)

Kandel ER, Kandel DB. A Molecular Basis for Nicotine as a Gateway Drug. N Engl J Med. 2014; 371(21):932-43. doi: 10.1056/NEJMsa1405092

Ren M, Lotfipour S. Nicotine Gateway Effects on Adolescent Substance Use. West J Emerg Med. 2019; 20(5):696-709. doi: 10.5811/westjem.2019.7.41661

Reed ZE, Wootton RE, Munafo MR. Using Mendelian Randomization to Explore the Gateway Hypothesis: Possible Causal Effects of Smoking Initiation and Alcohol Consumption on Substance Use Outcomes. Addiction. 2022; 117(3):741-50. doi: 10.1111/add.15673

de Dios MA, Bradley JA, Caviness CM; Stein MD. Early Quit Days Among Methadone-Maintained Smokers in a Smoking Cessation Trial. Nicotine Tob Res. 2014;16(11):1463-9. doi: 10.1093/ntr/ntu099.

Bureau of Justice Assistance. Comprehensive Opioid, Stimulant, and Substance Abuse Program (COSSAP). Polysubstance Use Among People Who Use Opioids. Washington, DC 20531: U.S. Department of Justiceꞌs Office of Justice Programs; 2021. (Available at: https://www.cossup.org) doi: 10.2810/161905

Hammond D, Wadsworth E, Reid JL, Burkhalter R. Prevalence and modes of cannabis use among youth in Canada, England, and the US, 2017 to 2019. Drug Alcohol Depend. 2021; 219: 108505. doi: 10.1016/j.drugalcdep.2020.108505

Cui Y, LoParco CR, Bar-Zeev Y, Duan Z, Levine H, Abroms LC, et al. Theory-based correlates of cannabis use and intentions among US and Israeli adults: a mixed methods study. Subst Abuse Treat Prev Policy. 2023;18(1):54. doi: 10.1186/s13011-023-00562-x.

Chun J. Public Health Threat of Tobacco and Substance Use in Asia: An Introduction to the Theme Issue. J Psychoactive Drugs. 2020; 52(1):1-4. doi: 10.1080/02791072.2020.1717686.

Condelli WS, Fairbank JA, Dennis ML, Rachel JV. Cocaine Use by Clients in Methadone Programs: Significance, Scope, and Behavioral Interventions. J Subst Abuse Treat. 1991;8(4):203-12. doi: 10.1016/0740-5472(91)90040-h.

Roux P, Lions C, Vilotitch A, Michel L, Mora M, Maradan G, et al. Correlates of cocaine use during methadone treatment: implications for screening and clinical management (ANRS Methaville study). Harm Reduct J. 2016; 13:12. doi: 10.1186/s12954-016-0100-7.

Khalili P, Nadimi AE, Baradaran HR, Janani L, Rahimi-Movaghar A, Rajabi Z, et al. Validity of self-reported substance use: research setting versus primary health care setting. Subst Abus Treat Prev Policy 2021;16(1):1-13. doi: 10.1186/s13011-021-00398-3.

Tran BX, Nguyen HLT, Le QNH, Mai HT, Ngo C, Hoang CD, et al. Alcohol and tobacco use among methadone maintenance patients in Vietnamese rural mountainside areas. Addict Behav Rep. 2017; 7:19-25. doi: 10.1016/j.abrep.2017.11.005.

Do HP, Nguyen LH, Nguyen NPT, Ngo C, Nguyen HLT, Le GT, et al. Factors associated with nicotine dependence during methadone maintenance treatment: findings from a multisite survey in Vietnam. BMJ Open. 2017:7(7): e015889. doi: 10.1136/bmjopen-2017-015889.

Ritter JM, Flower R, Henderson G, Loke YK, MacEwan, Rang HP. Rang & Dale's. Pharmacology. Ninth Edition. Elsevier; 2020.

USE OF PSYCHOACTIVE SUBSTANCES IN THE REGIONAL METHADONE CENTER IN SERBIA

Abstract

References